March 18, 2020 / 11:35 AM / 20 days ago

BRIEF-Revolution Medicines Announces Issuance Of U.S. Patent Covering Compositions Of Matter For Its Clinical-Stage Shp2 Inhibitor Program

March 18 (Reuters) - Revolution Medicines Inc:

* REVOLUTION MEDICINES ANNOUNCES ISSUANCE OF U.S. PATENT COVERING COMPOSITIONS OF MATTER FOR ITS CLINICAL-STAGE SHP2 INHIBITOR PROGRAM Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below